Historical First-Line Treatment Options for Lower-Risk MDS With Symptomatic Anemia

Commentary
Video

Amer Zeidan, MBBS, explains the treatment options for patients with lower-risk MDS prior to the approval of luspatercept.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
Related Content